EXHIBIT 31.1

           CERTIFICATION OF THE CHIEF EXECUTIVE AND FINANCIAL OFFICER

      I, Jitendra N. Doshi, the Chief Executive Officer and Chief Financial
Officer of Caraco Pharmaceutical Laboratories, Ltd. (the "registrant") certify
that:

1.    I have reviewed this quarterly report on Form 10-Q of the registrant;

2.    Based on my knowledge, this quarterly report does not contain any untrue
      statement of a material fact or omit to state a material fact necessary to
      make the statements made, in light of the circumstances under which such
      statements were made, not misleading with respect to the period covered by
      this quarterly report;

3.    Based on my knowledge, the financial statements, and other financial
      information included in this quarterly report, fairly present in all
      material respects the financial condition, results of operations and cash
      flows of the registrant as of, and for, the periods presented in this
      quarterly report;

4.    I am responsible for establishing and maintaining disclosure controls and
      procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) for
      the registrant and I have:

      a.    Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under my supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to me by others within those entities,
particularly during the period in which this quarterly report is being prepared;

      b.    {Intentionally omitted};

      c.    Evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report my conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

      d.    Disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during registrant's most recent
fiscal quarter (registrant's fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially
affect, registrant's internal control over financial reporting; and

5.    I have disclosed, based on my most recent evaluation of internal control
      over financial reporting, to the registrant's auditors and the audit
      committee of the board of directors (or persons fulfilling the equivalent
      functions):

      a.    All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

      b.    Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal control
over financial reporting.

October 20, 2004

                                              By: /s/ Jitendra N. Doshi
                                              -------------------------
                                              Jitendra N. Doshi
                                              Chief Executive Officer
                                              and Chief Financial Officer

                                      A-25